Russell Investments Group’s Enzo Biochem, Inc. ENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-125,292
Closed -$264K 3216
2020
Q3
$264K Sell
125,292
-238,041
-66% -$566K ﹤0.01% 2664
2020
Q2
$813K Buy
+363,333
New +$934K ﹤0.01% 2167
2018
Q4
Sell
-12,360
Closed -$50K 3048
2018
Q3
$50K Sell
12,360
-102,158
-89% -$464K ﹤0.01% 2833
2018
Q2
$593K Sell
114,518
-26,766
-19% -$163K ﹤0.01% 2337
2018
Q1
$774K Sell
141,284
-13,449
-9% -$94.7K ﹤0.01% 2318
2017
Q4
$1.29M Sell
154,733
-79,382
-34% -$758K ﹤0.01% 2024
2017
Q3
$2.45M Buy
234,115
+8,284
+4% +$91.9K ﹤0.01% 1669
2017
Q2
$2.49M Buy
225,831
+44,858
+25% +$418K ﹤0.01% 1606
2017
Q1
$1.51M Buy
180,973
+26,191
+17% +$185K ﹤0.01% 1889
2016
Q4
$1.07M Buy
+154,782
New +$988K ﹤0.01% 2134

Other funds holding ENZ

Russell Investments Group's ENZ Position: Q4 2020 in Review

Russell Investments Group sold out of Enzo Biochem, Inc. (ENZ) in Q4 2020, closing a stake of 125,292 shares — an estimated $264K sold.

Russell Investments Group first reported a position in ENZ in Q4 2016 and held it in 10 quarters. The position peaked at $2.49M in Q2 2017. 84 funds tracked by Wall St. Rank hold ENZ as of Q4 2020.

  • Russell Investments Group reported no remaining Enzo Biochem, Inc. position as of Q4 2020 after selling out during the quarter.
  • Russell Investments Group sold 125,292 Enzo Biochem, Inc. shares in Q4 2020, an estimated $264K.
  • Russell Investments Group first reported a position in Enzo Biochem, Inc. in Q4 2016 and held it in 10 quarters.
  • Russell Investments Group's Enzo Biochem, Inc. position peaked at $2.49M in Q2 2017.
  • 84 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2020.

Based on Russell Investments Group's 13F filing for Q4 2020, filed 8 Feb 2021.